Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of funding for the Innovative Medicines Fund to ensure (a) blood cancer patients and (b) other cancer patients can access treatments that would have been available through the Cancer Drugs Fund.

Proposals for the Innovative Medicines Fund (IMF) are in development. We expect NHS England and NHS Improvement and the National Institute for Health and Care Excellence to lead an engagement exercise in early 2021. The design and operation of the IMF, including the size of the fund, will reflect the outcome of the engagement exercise and as such, it is too soon to comment on any proposals.